Dashboard
My Portfolio
Backtest
New
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Zimmer Biomet Holdings, Inc. (ZBH)
Market Closed
16 Oct, 08:00 PM
NYSE
All
(10)
DE
(5)
AT
(1)
CH
(1)
IT
(1)
MX
(1)
US
(1)
NYSE
Primary
XWBO
SIX
XMEX
XSTU
XHAN
XFRA
XDUS
XMUN
XMIL
$
94.
98
+0.6
+0.6357%
$
18B
Market Cap
24.97
P/E Ratio
0.96%
Div Yield
1.94M
Volume
8.06
Eps
$
94.38
Previous Close
Investors:
TJD
DI
+222
Watching
Watch
Add Transaction
Day Range
94.24
95.91
Year Range
79.12
106.88
Want to track
ZBH
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Zimmer Biomet Holdings, Inc. (ZBH) Statistics
Valuation metrics
Market Cap
18B
Enterprise value
24.31B
Trailing P/E (ttm)
21.58
Forward P/E
10.35
PEG ratio
88.92
Price/Sales (ttm)
2.03
Price/Book (mrq)
1.36
Enterprise Value/Revenue
2.86
Enterprise Value/EBITDA
10.4
Overview
Shares outstanding
195.48M
Float
195.06M
Shares short
7.69M
% Held by insiders
0%
% Held by institutions
1.04%
Average volume (10 days)
2.12M
Average volume (90 days)
2.03M
Price summary
52-Week low
79.12
52-Week high
106.88
Beta
0.59
50-Day moving average
93.09
200-Day moving average
89.61
Dividends and splits
Forward annual dividend rate
0.96
Forward annual dividend yield
0.0103%
Trailing annual dividend rate
0.96
Trailing annual dividend yield
0.0108%
5-Year annual dividend yield
0.82%
Payout ratio
0.23
Dividend Date
31 Jul 2026
Ex-Dividend Date
25 Jun 2026
Last split factor
103:100
Last split Date
1 Mar 2022
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Dec 2025
Profitability
Profit margin
0.09%
Operating margin
0.16%
Operational effectiveness
Return on assets
0.04%
Return on equity
0.06%
Income Statement
Revenue (ttm)
8.23B
Revenue per share (ttm)
44.27
Quarterly revenue growth (yoy)
0.11%
Gross profit (ttm)
5.74B
EBITDA
2.48B
Net income to common (ttm)
705.1M
Diluted EPS (ttm)
4.2
Quarterly earnings growth (yoy)
-0.42%
Balance Sheet
Total cash (mrq)
620.9M
Total cash per share (mrq)
2.13
Total debt (mrq)
7.87B
Total Debt/Equity (mrq)
0.59
Current ratio (mrq)
1.69%
Book value per share (mrq)
65.73
Cash Flow
Cash flow statement
1.7B
Levered free cash flow (LFCF)
1.35B